Why the study?
Sickle cell trait and myocarditis share similar presentations during strenuous activity with potentially additive functional impairments, but literature has not established a causal association and information on their relationship is limited.
This case report describes a 26-year-old soldier with sickle cell trait who developed viral myocarditis following strenuous exertion, highlighting the overlapping presentations of these conditions.
Answers are grounded in this paper and cite their sources.
May aid differentiation of athlete's heart in similar cases; leaves open need for larger studies to refine thresholds.
Introduction Athletes and soldiers alike require adequate cardiovascular reserve to overcome the increased physiological demand for competitive sports and performance on the battlefield. Improving physical fitness (especially increases in aerobic exercise) can trigger adaptations in the heart which increases the cardiovascular reserve. Physiologic enlargement of the heart, increases in maximum oxygen consumption (V˙̇O2max), increased cardiac output and stroke volume, and decreased peripheral vascular resistance allow for better performance during training and competition (1). Physical fitness is established during unit training time and further developed and maintained on the soldier's personal time. Physical fitness tests are held once or twice a year and are used to measure the strength and endurance of the soldier. Passing the physical fitness tests can be problematic, especially if there are cardiovascular issues. Underlying cardiovascular disease, congenital or acquired, may have a range of responses from diminished exercise tolerance to cardiac arrest which can manifest during high levels of physical activity. With myocarditis, the individual's heart has lessened reserve and is thus less capable of providing the expected physical performance. Presentations of myocarditis in the athlete can be a decreased exercise tolerance, palpitations, precordial chest pain, or syncope (2). Individuals with a history of sickle cell trait also can have these same symptoms with strenuous activity, which if not addressed can lead to fulminant rhabdomyolysis and renal failure (3). Although current literature has not established a causal association between sickle cell trait and myocarditis, their presentations may be similar and their effects additive or synergistic in producing functional impairments, requiring addressing both conditions for successful control and treatment. Case Report Our 26-year-old active-duty soldier, known to be sickle cell trait-positive, drove himself to the emergency department after experiencing shortness of breath and chest pressure during the second lap (after about 800 m) of his annual physical fitness test. He stopped to rest due to the severity of his symptoms and was unable to complete the remaining mile. Previously he had no issues with the run, and he had received the highest run score the prior year. While in the emergency room, he denied any symptoms of lightheadedness, ongoing chest pressure, diaphoresis, nausea, or vomiting. He also denied any lower-extremity muscle pain, muscle weakness, or dark-colored urine, signs and symptoms which would have been concerning for rhabdomyolysis. He denied any family history of cardiac disease, sudden cardiac death, heart attack, or stroke in immediate family members younger than 50 years. He did report that his mother, who also was prior active duty and sickle trait-positive, had similar symptoms of fatigue and chest discomfort during a ruck march many years prior, but no further details were provided. The soldier's physical examination was unremarkable, but significant laboratory abnormalities were noted, to include troponin of 11.567 (N < 0.034), elevated erythrocyte sedimentation rate (ESR) of 61, C-reactive protein (CRP) of 10.9, D-Dimer 0.78 (N < 0.50), creatinine of 1.47 (baseline 1.00), and elevated ESR of 61, CRP of 10.9, D-Dimer 0.78 (N < 0.50), creatinine of 1.47 (baseline 1.00), and creatine kinase (CK) of 468 (30–225). Computed tomography (CT) pulmonary angiogram, transthoracic echocardiogram, and cardiac CT coronary were negative for any acute process and were reported as within normal limits. After the soldier completed his initial work-up in the emergency department, he was admitted to the telemetry ward for monitoring and continued cardiac risk stratification. The following day, a cardiac magnetic resonance imaging (MRI) was completed and revealed a subtle decrease in contractility of the inferolateral left ventricular wall and epicardial late gadolinium enhancement in the basal to midlateral wall and the distal inferolateral wall. These findings led to the diagnosis of myocarditis (Fig.).Figure: Sagittal view, cardiac MRI with and without gadolinium. Epicardial late gadolinium enhancement in the basal to mid lateral wall and the distal inferolateral wall (arrow). MRI findings consistent with myocarditis.He was monitored on telemetry throughout his hospital stay and his laboratories improved, including downtrending troponins and a return to baseline of creatinine and CK before discharge. Short of the reduced ability to exercise, he did not admit to or show signs of congestive heart failure (i.e., orthopnea, swelling in the distal legs, shortness of breath, or continued chest pain). He was put on a restricted activity profile to include no unit physical training or physical fitness test for the next 6 months and was scheduled for follow-up with the cardiologist in 2 months for reevaluation. Viral laboratories were drawn at discharge and were positive for Parvovirus B19 and Coxsackievirus B1-B6, A7, A9, A16, and A24. Discussion Myocarditis is a condition whose presentation varies widely, from a slow indolent process to fulminant precipitous cardiac failure. Myocarditis is, by definition, inflammation with necrosis of the myocardium (2). Symptoms range from weakness, shortness of breath, chest pain, and palpitations, to sudden cardiac death (4). There are multiple scoring systems for assessing disease severity, but in general, disease is graded as mild, moderate, or severe depending on the level of inflammation (2). Severe cases of myocarditis that lead to death have similar rates when comparing military to the National Collegiate Athletic Association (5). Common etiologies include viruses, ischemia, mechanical trauma, and after smallpox vaccination (2). Making the diagnosis of myocarditis is often difficult, given its relatively low prevalence leads to low levels of suspicion. In one study using the International Classification of Disease, the global prevalence of myocarditis was reported as 22 of every 100,000 individuals annually. Similarly, a study done on military recruits with suspected myocarditis, with a mean age of 20 years, showed an incidence of 98 of 670,000 recruits having the actual disease (6). If there is a concern for myocarditis, the gold standard for diagnosis is an endocardial muscle biopsy, though this is not commonly needed. In most cases, diagnosis can be made with a high level of clinical suspicion, an echocardiogram for functional status, and a gallium cardiac MRI to evaluate for myocardial inflammation. There also is the option of evaluating with an indium cardiac MRI to evaluate for the level of myocyte necrosis. Once the diagnosis is made, treatment choice depends on clinical severity. At the mild end of the treatment spectrum, for cases in which myocarditis presents slowly with barely noticeable chest pain or generalized weakness, only supportive care may be needed. Depending on the level of left ventricular dysfunction, an angiotensin-converting enzyme (ACE) inhibitor and beta blocker may be warranted. Those with New York Heart Association (NYHA) functional class III or IV demand more attention and aggressive intervention, as they have higher mortality rates (NYHA class 3 and 4 are, respectively, symptoms with minimal exertion that interfere with normal daily activity and an inability to carry out any physical activity) (7). In some circumstances, myocarditis can be so severe as to require intensive care with vasopressor support and potential surgical intervention in those with decompensated heart failure. Currently in study, largely in animal models, are the uses of both immunosuppression and antioxidants as treatments (2,7). Some examples of such are using prednisone for immunosuppression and melatonin for antioxidant effects. The milder cases typically require several days of inpatient observation, whereas more severe cases may require prolonged hospitalization; this is highly variable from case to case. A multitude of studies shows conflicting results regarding increased mortality risk based on presentations with mild versus severe symptoms (2). In general, there seems to be a consensus in the literature presented by the American College of Cardiology (ACC) and the American Heart Association (AHA) that mild cases typically have full resolution with appropriate treatment and counseling. It is pivotal that the patients receive not only the appropriate level of treatment that their condition warrants but also strong discharge counseling to limit all physical activity that would strain the myocardium further. The American Academy of Family Physicians' guidelines, which echo the ACC/AHA guidelines, recommends a 3- to 6-month follow up with repeat serum markers of myocardial injury, inflammation, and heart failure. Patients also should undergo 24-h Holter monitoring and an exercise EKG no less than 3 to 6 months after the illness, before return to activity. If there is any persistent/residual evidence of myocarditis, the patient should abstain from exercise (4,8–10). At this time, there is no proven causal association between sickle cell trait and myocarditis. However, sickle cell trait has been shown to increase the risk of exercise-related deaths by 28-fold in the U.S. military. The proposed mechanism is vigorous activity leading to the polymerization of hemoglobin S, causing vascular occlusion and endothelial damage (3). Further down the cascade, this process may lead to fulminant rhabdomyolysis, acute renal failure, disseminated intravascular coagulation, coronary vasoconstriction, and even sudden cardiac death. Despite known correlations between exercise-related cardiac mortality in both sickle cell trait and myocarditis, there remains a serious need for studies examining the relationship between myocarditis and sickle cell trait. See Table for a stepwise diagnostic assistant.Table: Stepwise diagnostic assistant.Conclusions Myocarditis as a disease process has been studied extensively in the literature. Our report is intended to further build on and support data confirming viral causes as the most common etiology, and to also raise questions about a particular variable in our patient: sickle cell trait. While this patient's presentation was similar to that of someone experiencing complications of sickle cell trait, such as shortness of breath or early muscle fatigue with sustained maximal exertion, the laboratories on admission showed no rhabdomyolysis or severe renal injury. There is ample available data, and more studies in progress, on the pathophysiology of viral myocarditis, but there appears to be a paucity of information on sickle cell trait in relation to myocarditis. This could be an avenue for new research to evaluate for prevalence of myocarditis in those with sickle cell trait compared with the general population and how this can impact treatment and outcome.
No takes yet. Share an insight, caveat, or question.
Lu et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: